These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 10659401)

  • 21. Non-uniform blockade of intrastriatal D2/D3 receptors by risperidone and amisulpride.
    Stone JM; Bressan RA; Erlandsson K; Ell PJ; Pilowsky LS
    Psychopharmacology (Berl); 2005 Aug; 180(4):664-9. PubMed ID: 15719226
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Domperidone: an alternative to orthopramides in the case of adverse reactions in the central nervous system].
    Buzo Sánchez LG; Artacho Criado S; Navarro Pulido AM; Orta Cuevas JC
    Med Clin (Barc); 1996 Sep; 107(8):317-8. PubMed ID: 8965498
    [No Abstract]   [Full Text] [Related]  

  • 23. Is regionally selective D2/D3 dopamine occupancy sufficient for atypical antipsychotic effect? an in vivo quantitative [123I]epidepride SPET study of amisulpride-treated patients.
    Bressan RA; Erlandsson K; Jones HM; Mulligan R; Flanagan RJ; Ell PJ; Pilowsky LS
    Am J Psychiatry; 2003 Aug; 160(8):1413-20. PubMed ID: 12900302
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dopamine D2/3 receptor antagonism reduces activity-based anorexia.
    Klenotich SJ; Ho EV; McMurray MS; Server CH; Dulawa SC
    Transl Psychiatry; 2015 Aug; 5(8):e613. PubMed ID: 26241351
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Etiological and therapeutical observations in a case of belly dancer's dyskinesia.
    Jabre M; Bejjani BP
    Mov Disord; 2006 Sep; 21(9):1536. PubMed ID: 16830316
    [No Abstract]   [Full Text] [Related]  

  • 26. Pharmacotoxicological aspects of levosulpiride.
    Rossi F; Forgione A
    Pharmacol Res; 1995 Feb; 31(2):81-94. PubMed ID: 7596959
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Domperidone: QT prolongation in infants.
    Prescrire Int; 2011 Jan; 20(112):14. PubMed ID: 21462787
    [No Abstract]   [Full Text] [Related]  

  • 28. [A case of the successful use of Motilium in treating reflux disease against a background of the hypothalamic syndrome of traumatic origin].
    Svintsyts'kyĭ AS; Dzeman MI; Shylo HV
    Lik Sprava; 1999 Jun; (4):145-7. PubMed ID: 10476668
    [No Abstract]   [Full Text] [Related]  

  • 29. Neurochemical characteristics of amisulpride, an atypical dopamine D2/D3 receptor antagonist with both presynaptic and limbic selectivity.
    Schoemaker H; Claustre Y; Fage D; Rouquier L; Chergui K; Curet O; Oblin A; Gonon F; Carter C; Benavides J; Scatton B
    J Pharmacol Exp Ther; 1997 Jan; 280(1):83-97. PubMed ID: 8996185
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Familial acute dystonic-dyskinetic syndrome with dominant inheritance after use of antidopaminergic antiemetic drugs.
    Macucci M; Dotti MT; Federico A
    Mov Disord; 1995 Jul; 10(4):528-9. PubMed ID: 7565844
    [No Abstract]   [Full Text] [Related]  

  • 31. Side-effects of benzamide derivatives.
    Benazzi F
    Int J Geriatr Psychiatry; 1997 Jan; 12(1):132. PubMed ID: 9050439
    [No Abstract]   [Full Text] [Related]  

  • 32. Low-dose amisulpride and elevation in serum prolactin.
    Andrade C
    J Clin Psychiatry; 2013 Jun; 74(6):e558-60. PubMed ID: 23842026
    [No Abstract]   [Full Text] [Related]  

  • 33. Anxiolytic-like effect of quinpirole in combination with a low dose of 17β-estradiol in ovariectomized rats.
    Fedotova J
    Acta Physiol Hung; 2013 Jun; 100(2):211-23. PubMed ID: 23708948
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Citalopram and levosulpiride: a dangerous drug combination for QT prolongation.
    Agosti S; Casalino L; Bertero G; Burrone A; Brunelli C; Morelloni S
    Am J Emerg Med; 2013 Nov; 31(11):1624.e1-2. PubMed ID: 23896010
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Foreword. The clinical aspects of deficit in dopaminergic ways.
    Gessa GL; Kasper S
    Int Clin Psychopharmacol; 2002 Dec; 17 Suppl 4():2 p following table of contents. PubMed ID: 12685915
    [No Abstract]   [Full Text] [Related]  

  • 36. [Urinary retention in 2 children after the use of antiemetic agents during acute gastroenteritis].
    de Moor RA; Diemont WL; Visser MO; van den Bemt PM
    Ned Tijdschr Geneeskd; 2005 Jun; 149(26):1472-4. PubMed ID: 16010961
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Sensorimotor gating and habituation of the startle response in schizophrenic patients randomly treated with amisulpride or olanzapine.
    Quednow BB; Wagner M; Westheide J; Beckmann K; Bliesener N; Maier W; Kühn KU
    Biol Psychiatry; 2006 Mar; 59(6):536-45. PubMed ID: 16139819
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Neuroleptic malignant syndrome due to amisulpride in a patient with solvent-induced chronic toxic encephalopathy.
    Peritogiannis V; Tsouli S; Pappas D; Mavreas V; Konitsiotis S
    Clin Neuropharmacol; 2007; 30(4):245-6. PubMed ID: 17762322
    [No Abstract]   [Full Text] [Related]  

  • 39. The broad-spectrum anti-emetic activity of AS-8112, a novel dopamine D2, D3 and 5-HT3 receptors antagonist.
    Yoshikawa T; Yoshida N; Oka M
    Br J Pharmacol; 2001 May; 133(2):253-60. PubMed ID: 11350861
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Risperidone augmentation with amisulpride: the blue-tongue sign.
    Yun HW; Lee BD
    Psychiatry Clin Neurosci; 2012 Aug; 66(5):464-5. PubMed ID: 22834673
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.